🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06793163
Recruiting Observational

Diagnosis and Allergen Identification of Perioperative Anaphylaxis

NCT06793163 · tracked via the Priya Life Science China tracker
Sponsor
Peking University First Hospital
Phase
Observational
Started
2025-01-25
Last updated
2026-06-18

Condition(s) studied

Perioperative/Postoperative ComplicationsAnaphylaxisTryptaseAllergensSkin Testing

Study summary

Perioperative anaphylaxis may lead to fatal respiratory and/or circulatory events, yet both clinical diagnosis and management are challenging. Serum tryptase is an indicator that can provide important retrospective diagnostic value for anaphylaxis. Another key point in perioperative anaphylaxis management is to identify the allergens, and thus avoid re-exposure during later perioperative management. Skin testing is an important way to identify allergens.

Eligibility

Sex
ALL
Min age
2 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Aged 2 years or over; * Suspected anaphylaxis in the operating rooms, or history of suspected anaphylaxis in the operating room. Exclusion Criteria: * Refuse to participate; * Other conditions that are considered unsuitable for study participation.

Primary outcome measure(s)

Trial sites (6)

FacilityCityRegionStatus
Peking University First Hospital Beijing Beijing Municipality Recruiting
Beijing Anorectal Hospital (Beijing Erlong Road Hospital) Beijing Beijing Municipality Recruiting
Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, China Beijing Beijing Municipality Recruiting
Beijing Friendship Hospital, Capital Medical University Beijing Beijing Municipality Recruiting
Beijing Tongren Hospital, Capital Medical University Beijing Beijing Municipality Not Yet Recruiting
Peking University First Hospital Beijing Beijing Municipality Recruiting

More Peking University First Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06793163 on ClinicalTrials.gov ↗ ← All trials in China